Feasibility of CBCT-guided online adaptive radiotherapy

Feasibility of CBCT-guided online adaptive radiotherapy - FASCINATE

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON53283

Enrollment

100

Registered

2023-07-07

Start date

2023-08-29

Completion date

Unknown

Last updated

2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder cervix lung or head and neck cancer Prostate

Interventions

In parallel cohorts, multiple implementations of CBCT-guided online adaptive radiotherapy are studied conform the specific study manual.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patient with tumor type of one of the cohorts Age >= 18 years Scheduled to undergo online adaptive CBCT-guided radiation therapy. WHO performance score 0*3. Ability to give oral and written informed consent

Exclusion criteria

Exclusion criteria: Pregnancy

Design outcomes

Primary

Measure	Time frame
The feasibility of online CBCT-guided adaptive radiation therapy on a standard Elekta Linac.	—

Secondary

Measure	Time frame
Treatment associated >= grade 3 acute toxicity according to the NCI Common Terminology Criteria of Adverse Events (CTCAE version 4.03).	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)